{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:29:12Z","timestamp":1772119752661,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82270183"],"award-info":[{"award-number":["No.82270183"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-11147-1","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T07:45:06Z","timestamp":1761032706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro study on reversible regulation of CAR-T function by Kinsenoside"],"prefix":"10.1007","volume":"52","author":[{"given":"Guangmei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangwu","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengju","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"12","key":"11147_CR1","doi-asserted-by":"publisher","first-page":"e930","DOI":"10.1016\/S2352-3026(22)00291-5","volume":"9","author":"Y Hu","year":"2022","unstructured":"Hu Y, Feng J, Gu T, Wang L, Wang Y, Zhou L et al (2022) CAR T-cell therapies in China: rapid evolution and a bright future. Lancet Haematol 9(12):e930\u2013e41","journal-title":"Lancet Haematol"},{"issue":"10","key":"11147_CR2","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ajh.26301","volume":"96","author":"JR Westin","year":"2021","unstructured":"Westin JR, Kersten MJ, Salles G, Abramson JS, Schuster SJ, Locke FL et al (2021) Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed\/refractory aggressive B-cell lymphomas: observations from the JULIET, ZUMA-1, and TRANSCEND trials. Am J Hematol 96(10):1295\u20131312","journal-title":"Am J Hematol"},{"issue":"6382","key":"11147_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June CH, O\u2019Connor RS, Kawalekar OU, Ghassemi S, Milone MC (2018) CAR T cell immunotherapy for human cancer. Science 359(6382):1361\u20131365","journal-title":"Science"},{"issue":"1","key":"11147_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/clinchem\/hvad179","volume":"70","author":"T Mamo","year":"2024","unstructured":"Mamo T, Dreyzin A, Stroncek D, McKenna DH (2024) Emerging biomarkers for monitoring chimeric antigen receptor T-Cell therapy. Clin Chem 70(1):116\u2013127","journal-title":"Clin Chem"},{"issue":"690","key":"11147_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abk1900","volume":"15","author":"D Meyran","year":"2023","unstructured":"Meyran D, Zhu JJ, Butler J, Tantalo D, MacDonald S, Nguyen TN et al (2023) T(STEM)-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models. Sci Transl Med 15(690):eabk1900","journal-title":"Sci Transl Med"},{"issue":"5","key":"11147_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","volume":"24","author":"JA Fraietta","year":"2018","unstructured":"Fraietta JA, Lacey SF, Orlando EJ, Pruteanu-Malinici I, Gohil M, Lundh S et al (2018) Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat Med 24(5):563\u2013571","journal-title":"Nat Med"},{"issue":"22","key":"11147_CR7","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1056\/NEJMoa2401361","volume":"390","author":"MP Hamilton","year":"2024","unstructured":"Hamilton MP, Sugio T, Noordenbos T, Shi S, Bulterys PL, Liu CL et al (2024) Risk of second tumors and T-cell lymphoma after CAR T-cell therapy. N Engl J Med 390(22):2047\u20132060","journal-title":"N Engl J Med"},{"issue":"8","key":"11147_CR8","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.ccell.2024.07.002","volume":"42","author":"U Uslu","year":"2024","unstructured":"Uslu U, Castelli S, June CH (2024) CAR T cell combination therapies to treat cancer. Cancer Cell 42(8):1319\u20131325","journal-title":"Cancer Cell"},{"issue":"23","key":"11147_CR9","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1182\/blood.2020008865","volume":"137","author":"P Strati","year":"2021","unstructured":"Strati P, Ahmed S, Furqan F, Fayad LE, Lee HJ, Iyer SP et al (2021) Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood 137(23):3272\u20133276","journal-title":"Blood"},{"issue":"6258","key":"11147_CR10","doi-asserted-by":"publisher","first-page":"aab4077","DOI":"10.1126\/science.aab4077","volume":"350","author":"CY Wu","year":"2015","unstructured":"Wu CY, Roybal KT, Puchner EM, Onuffer J, Lim WA (2015) Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. Science 350(6258):aab4077","journal-title":"Science"},{"key":"11147_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fphar.2014.00254","volume":"5","author":"BS Jones","year":"2014","unstructured":"Jones BS, Lamb LS, Goldman F, Di Stasi A (2014) Improving the safety of cell therapy products by suicide gene transfer. Front Pharmacol 5:254","journal-title":"Front Pharmacol"},{"key":"11147_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1126\/scitranslmed.aau5907","volume":"11","author":"K Mestermann","year":"2019","unstructured":"Mestermann K, Giavridis T, Weber J, Rydzek J, Frenz S, Nerreter T et al (2019) The tyrosine kinase inhibitor dasatinib acts as a Pharmacologic on\/off switch for CAR T cells. Sci Transl Med 11:499","journal-title":"Sci Transl Med"},{"issue":"1","key":"11147_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.chembiol.2020.10.004","volume":"28","author":"B Zhang","year":"2021","unstructured":"Zhang B, Wang Y, Huang S, Sun J, Wang M, Ma W et al (2021) Photoswitchable CAR-T cell function in vitro and in vivo via a cleavable mediator. Cell Chem Biol 28(1):60\u2013 \u2013\u20099.e7","journal-title":"Cell Chem Biol"},{"issue":"11","key":"11147_CR14","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.7150\/ijbs.77720","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang X, Li J, Chen R, Li T, Chen M (2023) Active ingredients from Chinese medicine for combination cancer therapy. Int J Biol Sci 19(11):3499\u20133525","journal-title":"Int J Biol Sci"},{"key":"11147_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153575","volume":"87","author":"X Yang","year":"2021","unstructured":"Yang X, Feng Y, Liu Y, Ye X, Ji X, Sun L et al (2021) Fuzheng jiedu xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT\/CyclinD1\/p21\/p27 pathway. Phytomedicine 87:153575","journal-title":"Phytomedicine"},{"key":"11147_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109167","volume":"117","author":"C Ma","year":"2019","unstructured":"Ma C, Wei Y, Liu Q, Xin Y, Cao G, Wang X (2019) Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells. Biomed Pharmacother 117:109167","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"11147_CR17","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1002\/ijc.26316","volume":"130","author":"SA Ju","year":"2012","unstructured":"Ju SA, Park SM, Lee YS, Bae JH, Yu R, An WG et al (2012) Administration of 6-gingerol greatly enhances the number of tumor-infiltrating lymphocytes in murine tumors. Int J Cancer 130(11):2618\u20132628","journal-title":"Int J Cancer"},{"issue":"11","key":"11147_CR18","doi-asserted-by":"publisher","first-page":"e110040","DOI":"10.1371\/journal.pone.0110040","volume":"9","author":"S Banerjee","year":"2014","unstructured":"Banerjee S, Ghosh T, Barik S, Das A, Ghosh S, Bhuniya A et al (2014) Neem leaf glycoprotein prophylaxis transduces immune dependent stop signal for tumor angiogenic switch within tumor microenvironment. PLoS ONE 9(11):e110040","journal-title":"PLoS ONE"},{"issue":"8","key":"11147_CR19","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1158\/1078-0432.CCR-18-1527","volume":"25","author":"G Alatrash","year":"2019","unstructured":"Alatrash G, Qiao N, Zhang M, Zope M, Perakis AA, Sukhumalchandra P et al (2019) Fucosylation enhances the efficacy of adoptively transferred antigen-specific cytotoxic T lymphocytes. Clin Cancer Res 25(8):2610\u20132620","journal-title":"Clin Cancer Res"},{"issue":"1","key":"11147_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02148-6","volume":"40","author":"X Xiao","year":"2021","unstructured":"Xiao X, Huang S, Chen S, Wang Y, Sun Q, Xu X et al (2021) Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies. J Exp Clin Cancer Res 40(1):367","journal-title":"J Exp Clin Cancer Res"},{"key":"11147_CR21","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"issue":"6","key":"11147_CR22","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1073\/pnas.0914318107","volume":"107","author":"VM Lepp\u00e4nen","year":"2010","unstructured":"Lepp\u00e4nen VM, Prota AE, Jeltsch M, Anisimov A, Kalkkinen N, Strandin T et al (2010) Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc Natl Acad Sci U S A 107(6):2425\u20132430","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"11147_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47(7):1739\u20131749","journal-title":"J Med Chem"},{"issue":"4","key":"11147_CR24","first-page":"301","volume":"22","author":"T Yu","year":"2025","unstructured":"Yu T, Wang X, Bai O, Zhang H, Qian W (2025) Advances in strategies to improve the immunotherapeutic efficacy of chimeric antigen receptor-T cell therapy for lymphoma. Cancer Biol Med 22(4):301\u2013321","journal-title":"Cancer Biol Med"},{"issue":"6","key":"11147_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","volume":"24","author":"M Norelli","year":"2018","unstructured":"Norelli M, Camisa B, Barbiera G, Falcone L, Purevdorj A, Genua M et al (2018) Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells. Nat Med 24(6):739\u2013748","journal-title":"Nat Med"},{"key":"11147_CR26","doi-asserted-by":"publisher","first-page":"702211","DOI":"10.3389\/fimmu.2021.702211","volume":"12","author":"F Huang","year":"2021","unstructured":"Huang F, Hu L, Zhang Y, Qu X, Xu J (2021) BMP4 moderates Glycolysis and regulates activation and Interferon-Gamma production in CD4\u2009+\u2009T cells. Front Immunol 12:702211","journal-title":"Front Immunol"},{"issue":"5","key":"11147_CR27","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/j.ymthe.2025.04.006","volume":"33","author":"A Cadinanos-Garai","year":"2025","unstructured":"Cadinanos-Garai A, Flugel CL, Cheung A, Jiang E, Vaissie A, Abou-El-Enein M (2025) High-dimensional Temporal mapping of CAR T cells reveals phenotypic and functional remodeling during manufacturing. Mol Ther 33(5):2291\u20132309","journal-title":"Mol Ther"},{"key":"11147_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1009550","volume":"13","author":"L Lu","year":"2022","unstructured":"Lu L, Xiong Y, Lin Z, Chu X, Panayi AC, Hu Y et al (2022) Advances in the therapeutic application and pharmacological properties of Kinsenoside against inflammation and oxidative stress-induced disorders. Front Pharmacol 13:1009550","journal-title":"Front Pharmacol"},{"key":"11147_CR29","doi-asserted-by":"crossref","unstructured":"Cheng CF, Lu CW, Wu WJ, Su LY, Nguyen TKN, Shen SC et al (2023) Therapeutic effects of plant extracts of Anoectochilus Roxburghii on side effects of chemotherapy in BALB\/c breast cancer mice. Plants (Basel). ;12(13):2494","DOI":"10.3390\/plants12132494"},{"issue":"1","key":"11147_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11596-018-1841-1","volume":"38","author":"CX Qi","year":"2018","unstructured":"Qi CX, Zhou Q, Yuan Z, Luo ZW, Dai C, Zhu HC et al (2018) Kinsenoside: a promising bioactive compound from Anoectochilus species. Curr Med Sci 38(1):11\u201318","journal-title":"Curr Med Sci"},{"key":"11147_CR31","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3389\/fphar.2018.00807","volume":"9","author":"Y Ho","year":"2018","unstructured":"Ho Y, Chen YF, Wang LH, Hsu KY, Chin YT, Yang YSH et al (2018) Inhibitory effect of Anoectochilus formosanus extract on Hyperglycemia-Related PD-L1 expression and cancer proliferation. Front Pharmacol 9:807","journal-title":"Front Pharmacol"},{"issue":"6","key":"11147_CR32","first-page":"928","volume":"11","author":"LF Shyur","year":"2004","unstructured":"Shyur LF, Chen CH, Lo CP, Wang SY, Kang PL, Sun SJ et al (2004) Induction of apoptosis in MCF-7 human breast cancer cells by phytochemicals from Anoectochilus formosanus. J Biomed Sci 11(6):928\u2013939","journal-title":"J Biomed Sci"},{"issue":"1","key":"11147_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12032-023-02231-2","volume":"41","author":"BA Gunes","year":"2023","unstructured":"Gunes BA, Ozkan T, Gonulkirmaz N, Sunguroglu A (2023) The evaluation of the anti-cancer effects of Anoectochilus Roxburghii on hematological cancers in vitro. Med Oncol 41(1):6","journal-title":"Med Oncol"},{"issue":"7","key":"11147_CR34","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1053\/j.gastro.2009.02.049","volume":"136","author":"R Caruso","year":"2009","unstructured":"Caruso R, Sarra M, Stolfi C, Rizzo A, Fina D, Fantini MC et al (2009) Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Gastroenterology 136(7):2270\u20132279","journal-title":"Gastroenterology"},{"issue":"1","key":"11147_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00897-z","volume":"13","author":"D Wang","year":"2020","unstructured":"Wang D, Yu W, Lian J, Wu Q, Liu S, Yang L et al (2020) Th17 cells inhibit CD8(+) T cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients. J Hematol Oncol 13(1):68","journal-title":"J Hematol Oncol"},{"key":"11147_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1073\/pnas.2106612118","volume":"118","author":"L Yang","year":"2021","unstructured":"Yang L, Yin J, Wu J, Qiao L, Zhao EM, Cai F et al (2021) Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule Resveratrol. Proc Natl Acad Sci U S A 118:34","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11147-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T05:04:57Z","timestamp":1766898297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11147-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["11147"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11147-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7277929\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All samples were obtained according to the protocols approved by Tongji Medical College and the Hubei Provincial Ethics Committee (NCT05388695).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent"}}],"article-number":"1047"}}